สหรัฐอเมริกา - อังกฤษ - NLM (National Library of Medicine)

k.boeun pharmaceutical co.,ltd. - sodium monofluorophosphate (unii: c810jcz56q) (fluoride ion - unii:q80vpu408o), calcium phosphate, dibasic, anhydrous (unii: l11k75p92j) (calcium phosphate, dibasic, anhydrous - unii:l11k75p92j), calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), alcloxa (unii: 18b8o9dqa2) (alcloxa - unii:18b8o9dqa2), aminocaproic acid (unii: u6f3787206) (aminocaproic acid - unii:u6f3787206) - for dental care apply an appropriate amount to your toothbrush and brush your teeth by brushing.

สหรัฐอเมริกา - อังกฤษ - NLM (National Library of Medicine)

team j f&b co., ltd. - silicon dioxide (unii: etj7z6xbu4) (silicon dioxide - unii:etj7z6xbu4), alcloxa (unii: 18b8o9dqa2) (alcloxa - unii:18b8o9dqa2), aminocaproic acid (unii: u6f3787206) (aminocaproic acid - unii:u6f3787206) - purpose: anticavity uses: helps protect against cavities

นิวซีแลนด์ - อังกฤษ - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - active: tranexamic acid 100 mg/ml excipient: nitrogen water for injection - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. localfibrinolysis may occur in the following conditions: · prostatectomy and bladder surgery · menorrhagia · epistaxis · conisation of the cervix · management of dental extraction in patients with coagulopathies · ulcerative colitis · haematuria (tranexamic acid therapy is not indicated in haematuria caused by diseases of the renal parenchyma (also see precautions). · gastrointestinal haemorrhage

นิวซีแลนด์ - อังกฤษ - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - active: tranexamic acid 100 mg/ml excipient: nitrogen water for injection - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. localfibrinolysis may occur in the following conditions: · prostatectomy and bladder surgery · menorrhagia · epistaxis · conisation of the cervix · management of dental extraction in patients with coagulopathies · ulcerative colitis · haematuria (tranexamic acid therapy is not indicated in haematuria caused by diseases of the renal parenchyma (also see precautions). · gastrointestinal haemorrhage

ออสเตรเลีย - อังกฤษ - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - tranexamic acid, quantity: 500 mg - injection, solution - excipient ingredients: water for injections - adults for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. paediatrics for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

ออสเตรเลีย - อังกฤษ - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - tranexamic acid, quantity: 1000 mg - injection, solution - excipient ingredients: water for injections - adults for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. paediatrics for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

ออสเตรเลีย - อังกฤษ - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid -

ออสเตรเลีย - อังกฤษ - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid -

ออสเตรเลีย - อังกฤษ - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid -

ออสเตรเลีย - อังกฤษ - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid -